Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms (American Journal of Hematology, 2024)

(untitled) - Gurban, P; Mambet, C; Botezatu, A; Necula, LG; Matei, L; Neagu, AI; Pitica, I; Ataman, M; Tatic, A; Bardas, A; Gaman, MA; Dobrea, C; et al.